DEXCOM INC (DXCM) Financials
Annual revenue, profitability and per-share results for DEXCOM INC, as reported in SEC filings.
Revenue · FY2025
$4.66B
▲ 15.6%YoY
Net income · FY2025
$836.30M
▲ 45.1%YoY
Gross margin · FY2025
60.1%
Diluted EPS · FY2025
$2.09
▲ 47.2%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $4.66B | $836.30M | $2.80B | $2.09 | $1.08B | 19.6% | +15.6% |
| FY2024 | $4.03B | $576.20M | $2.44B | $1.42 | $630.70M | 14.9% | +11.3% |
| FY2023 | $3.62B | $541.50M | $2.29B | $1.30 | $511.90M | 16.5% | +24.5% |
| FY2022 | $2.91B | $341.20M | $1.88B | $0.82 | $304.70M | 13.4% | +18.8% |
Figures as reported in DEXCOM INC's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a DXCM filing.
Get an email when DXCM files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.